Light, dopamine, and myopia

Time outdoors has a protective effect against myopia that may be mediated by the high illuminance (brightness) of outdoor light. The importance of children receiving adequate exposure to daylight is now recognized by many specialists,1 but why does bright light protect against myopia? The primary hypothesis is that bright light stimulates dopamine release in the […]

The protective effect of time outdoors against myopia

There are now a number of studies supporting the protective role of time outdoors against myopia. 1 Randomized controlled trials conducted in China and Taiwan have found that increasing the amount of time children spend outdoors reduces the incidence rate of myopia. 2,3 According to a meta-analysis, one additional hour of time outdoors each week […]

Circadian rhythms and myopia

Both environmental and genetic factors contribute to the complex etiology of myopia, yet the precise causes and mechanisms underlying myopia development remain unknown.1 There is accumulating evidence in humans for an association between myopia and disturbed sleep,2 but is the circadian system involved? In animals, changing the light-dark cycle (and thus the circadian rhythm) interferes […]

The relationship between myopia and sleep

Myopia impacts a variety of aspects of life, and more and more research is now pointing towards a relationship between myopia and sleep. Studies in children, adolescents, and adults have found that people with myopia go to bed later than people without myopia.1,2,3 Children with myopia also tend to have more variable sleep durations4 and […]

The impact of myopia on quality of life

The effects of myopia on visual function and the long-term risks of ocular health complications are well-documented.1 Yet the influence myopia can have on quality of life and psychosocial functioning is often overlooked. As an increasing number of children and adolescents develop myopia,2 it is important to consider all of the burdens associated with myopia […]

COVID-19 and the myopia epidemic

Globally, myopia impacts every 1 in 3 people, on average, and its prevalence is expected to continue to increase. It is projected that 50% of the world’s population will be myopic by 2050.¹ In 2020, as the world went into lockdown, concerns were raised about the potential for home confinement during the COVID-19 pandemic to […]

Dopavision presents new research at ARVO virtual conference

Dopavision is presenting its new research findings at the ARVO conference, which is held virtually this year. The ARVO conference is the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) and one of the largest research conferences in vision world-wide, gathering key opinion leaders and experts in ophthalmology and myopia from […]

Dopavision featured in German TV magazine 3sat NANO

Dopavision was featured in today’s edition of the TV science program NANO by German TV station 3sat. For some time, scientists have observed that myopia is increasing at an unprecedented rate. New evidence shows that changes in visual behavior at work, school and during leisure time are driving the increase in myopia. This trend is […]

Dopavision’s Tim Schilling to present at myopia webinights online seminar

Tim Schilling will present today in the virtual Myopia Webinights format on the state of research on the role of dopamine in myopia. Myopia Webinights is a series of online talks on the science around myopia, intervention possibilities, and managing myopia in daily clinical care. It is directed at scientists, ophthalmologists and optometrists, regularly draws […]